Related Experiment Video
Updated: Apr 28, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
1.8K
Akathisia treated with olanzapine: Three case reports
Farida Yousaf1, Antonio Fialho, Matthew Warden
1Leatherhead Community Mental Health Team, Leatherhead, UK.
International Journal of Psychiatry in Clinical Practice
|June 14, 2014
Summary
Olanzapine effectively treats neuroleptic-induced akathisia, offering a promising alternative to clozapine. This study highlights olanzapine
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience and Behavioral Science
Background:
- Neuroleptic-induced akathisia is a distressing side effect of antipsychotic medications.
- Clozapine has shown efficacy but is limited by its side effect profile.
- Olanzapine shares receptor occupancy and structural similarities with clozapine.
Purpose of the Study:
- To evaluate the effectiveness of olanzapine in treating neuroleptic-induced akathisia.
- To present case studies demonstrating olanzapine's therapeutic potential for this condition.
Main Methods:
- Retrospective review of three patient cases.
- Administration of olanzapine for neuroleptic-induced akathisia.
- Clinical observation of symptom improvement.
Main Results:
- All three patients experienced significant improvement in akathisia symptoms after commencing olanzapine.
- Olanzapine demonstrated a rapid and dramatic reduction in akathisia severity.
- No significant adverse events related to olanzapine were reported in these cases.
Conclusions:
- Olanzapine appears to be an effective treatment for neuroleptic-induced akathisia.
- Its favorable side effect profile compared to clozapine makes it a viable therapeutic option.
- Further research is warranted to confirm these findings in larger patient populations.
More Related Videos
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
13.6K
11:17Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
1.1K
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:24Mania and Antimanic Drugs: Overview
793
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
793
01:21Antipsychotic Drugs: Typical and Atypical Agents
1.3K
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
1.3K
01:23Antidepressant Drugs: MAOIs and Other Agents
1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
01:20Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
01:26Anxiolytic Drugs: Overview
1.5K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.5K